Introducing Illumina Microbial Amplicon Prep Solutions

2023년 9월 18일

Illumina proudly introduces two new library prep solutions built on the simple and affordable COVIDSeq(TM) workflow. Illumina Microbial Amplicon Prep (IMAP) and Illumina Microbial Amplicon Prep—Influenza A/B (IMAP-Flu) will help build global genomic surveillance capabilities and power impactful microbiology research. In the genome era, infectious diseases don’t have to be a disaster. For more information on IMAP and IMAP-Flu: https://www.illumina.com/destination/imap.html #genomics #illumina #microbiology

다음을 통해 기사 공유하기:    
    
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

정확한 번역을 제공하고자 합당한 노력을 기울였으나, 자동 번역은 완벽하지 않으며, 그 목적 또한 원문을 대체하기 위함이 아닙니다. 공식 콘텐츠는 영문 버전의 원문 콘텐츠임을 참고 부탁드립니다.
Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/ko-kr/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.